HUTCHMED (CHINA) LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 290 GBX | -4.61% |
|
+7.41% | +2.47% |
| 26/04 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
| 26/04 | Hutchmed notes CHMP's positive opinion for fruiquintinib approval | AN |
Chart calendar HUTCHMED (China) Limited
1d2e2a61542.CtVINs8QhoLc4mp4t1lm-XkEvDCkunk7SZDJmHZxWjw.YpoFcYVJ0diEsRMywhEhthVGhVz77CNsA-OirQAJDk9Noj15gGXpx-zPUg~366d2cb0d2a41883bb0a52c8a191cecb
Upcoming events on HUTCHMED (China) Limited
Past events on HUTCHMED (China) Limited
| 20/03/2024 | European Lung Cancer Congress |
| 19/03/2024 | Guotai Junan Healthcare Globalization Forum |
| 12/03/2024 | Soochow Securities Innovative Drug Forum and BD Conference |
| 07/03/2024 | Guangfa Securities Spring Conference |
| 28/02/2024 06:00 pm | Q4 2023 Earnings Call |
| 28/02/2024 | Q4 2023 Earnings Release |
| 07/02/2024 01:30 am | American Society of Clinical Oncology Plenary Series Session - Abstract 438730 |
| 18/01/2024 | Citi China Healthcare Corporate Day |
| 11/01/2024 | Sinolink Securities Spring Strategy Conferenc |
| 07/12/2023 | ESMO Immuno Oncology Congress - Poster No 74P |
| 07/12/2023 | ESMO Immuno Oncology Congress - Poster No 124P |
| 02/12/2023 03:20 pm | European Society for Medical Oncology Asia Congress - Abstract No 93P |
| 02/12/2023 03:20 pm | European Society for Medical Oncology Asia Congress - Abstract No 496P |
| 02/12/2023 | European Society for Medical Oncology Asia Congress - Poster No 186P |
| 02/12/2023 | European Society for Medical Oncology Asia Congress - Poster No 96P |
| 01/12/2023 09:20 am | European Society for Medical Oncology Asia Congress - Abstract No 77MO |
| 01/12/2023 08:55 am | European Society for Medical Oncology Asia Congress - Abstract No 289MO |
| 14/11/2023 | Jefferies London Healthcare Conference |
| 09/11/2023 07:00 pm | Deutsche Bank Depositary Receipts Virtual Investor Conference |
| 07/11/2023 | Citi China Investor Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 205 197 3.87% | 228 219 4.02% | 356 339 5.12% | 426 410 4.06% | 838 800 4.81% | 681 |
|
EBITDA Million USD | Released Forecast Spread | -141 -138 -2.61% | -191 -171 -11.34% | -321 -315 -2.02% | -399 -386 -3.38% | 26,6 -31,8 183.56% | -150 |
|
EBIT Million USD | Released Forecast Spread | -146 -143 -2.67% | -197 -180 -9.04% | -328 -322 -2.04% | -408 -394 -3.44% | 18,4 -41,1 144.67% | -153 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -141 -152 6.98% | -190 -190 0.11% | -216 -297 27.35% | -410 -380 -7.98% | 58,3 -6,88 947.71% | -142 |
|
Net income Million USD | Released Forecast Spread | -106 -121 12.33% | -126 -130 3.43% | -195 -256 23.84% | -361 -368 1.82% | 101 12,3 716.24% | -109 |
|
EPS USD | Released Forecast Spread | -0,16 -0,18 11.72% | -0,18 -0,20 11.33% | -0,25 -0,35 29.19% | -0,43 -0,44 2.37% | 0,12 0,01 1076.47% | -0,14 |
| Announcement Date | 03/03/20 | 04/03/21 | 03/03/22 | 28/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 | 2025 S1 | 2025 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 103 120 -14.11% | 107 94,1 13.51% | 121 109 10.92% | 157 136 15.49% | 199 180 10.35% | 202 175 15.31% | 224 210 6.82% | 533 308 73.05% | 305 301 1.39% | 322 | 349 | 405 | 415 |
|
EBIT Million USD | Released Forecast Spread | -78,2 -84,6 7.61% | -119 -134 11.3% | -144 -161 10.73% | -185 -185 0.35% | -197 -199 1.11% | -211 -222 5.19% | 112 -115 197.22% | -93,3 -138 32.46% | -65,2 | -79,6 | -61,4 | -67,5 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -76,6 -84,8 9.69% | -113 -132 14.54% | -140 -179 21.36% | -75,3 -177 57.57% | -201 -200 -0.22% | -210 -240 12.44% | -78,8 -203 61.19% | -39,7 | -103 | ||||
|
Net income Million USD | Released Forecast Spread | -49,7 -60,7 18.13% | -76,0 -86,7 12.3% | -102 -153 32.99% | -92,3 -127 27.42% | -163 -186 12.2% | -198 -232 14.56% | -67,8 -182 62.8% | -52,6 | -64,3 | ||||
| Announcement Date | 03/03/20 | 30/07/20 | 04/03/21 | 28/07/21 | 03/03/22 | 01/08/22 | 28/02/23 | 31/07/23 | 28/02/24 | - | - | - | - |
More events
Past sector events for HUTCHMED (China) Limited
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- HCM Stock
- Calendar HUTCHMED (China) Limited
